BIOMAT Database Logo BIOMAT Database Logo

Continuous infusion of amphotericin B deoxycholate: does decreased nephrotoxicity couple with time-dependent pharmacodynamics? 2006

Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D003840 Deoxycholic Acid A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Deoxycholate,Desoxycholic Acid,Kybella,Choleic Acid,Deoxycholic Acid, 12beta-Isomer,Deoxycholic Acid, 3beta-Isomer,Deoxycholic Acid, 5alpha-Isomer,Deoxycholic Acid, Disodium Salt,Deoxycholic Acid, Magnesium (2:1) Salt,Deoxycholic Acid, Monoammonium Salt,Deoxycholic Acid, Monopotassium Salt,Deoxycholic Acid, Monosodium Salt,Deoxycholic Acid, Sodium Salt, 12beta-Isomer,Dihydroxycholanoic Acid,Lagodeoxycholic Acid,Sodium Deoxycholate,12beta-Isomer Deoxycholic Acid,3beta-Isomer Deoxycholic Acid,5alpha-Isomer Deoxycholic Acid,Deoxycholate, Sodium,Deoxycholic Acid, 12beta Isomer,Deoxycholic Acid, 3beta Isomer,Deoxycholic Acid, 5alpha Isomer
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Minimizing nephrotoxicity using continuous infusion of deoxycholate amphotericin B.
October 2014, The Pediatric infectious disease journal,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Amphotericin B deoxycholate administered by continuous infusion: does the dosage make a difference?
April 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Nephrotoxicity of cyclosporine A and amphotericin B-deoxycholate as continuous infusion in allogenic stem cell transplantation.
June 2002, Swiss medical weekly,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Reduction of nephrotoxicity associated with amphotericin B deoxycholate.
January 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Nephrotoxicity associated with amphotericin B deoxycholate in neonates.
December 2009, The Pediatric infectious disease journal,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.
January 2013, PloS one,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus.
May 2015, Antimicrobial agents and chemotherapy,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting.
August 2014, The Pediatric infectious disease journal,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study.
April 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Francesco G de Rosa, and Olivia Bargiacchi, and Sabrina Audagnotto, and Silvia Garazzino, and V Marco Ranieri, and Giovanni di Perri
Continuous infusion of amphotericin B deoxycholate for the treatment of life-threatening Candida infections.
October 2013, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!